Matuzumab

DRUG2 trials

Sponsors

EMD Serono, Merck KGaA, Darmstadt, Germany

Conditions

Esophageal CancerGastric CancerLung CancerNon Small Cell Lung Carcinoma

Phase 2

Effects of Matuzumab in Combination With Pemetrexed for the Treatment of Advanced Lung Cancer

CompletedNCT00111839

EMD SeronoLung Cancer, Non Small Cell Lung Carcinoma

Start: 2005-05-31End: 2009-03-31Updated: 2018-04-06

Matuzumab Treatment With Epirubicin, Cisplatin and Capecitabine (ECX) in Esophago-Gastric Cancer

CompletedNCT00215644

Merck KGaA, Darmstadt, GermanyEsophageal Cancer, Gastric Cancer

Start: 2005-08-31End: 2008-08-31Updated: 2018-11-02